As of 2024-12-14, the Intrinsic Value of Inspire Medical Systems Inc (INSP) is
5.51 USD. This INSP valuation is based on the model Peter Lynch Fair Value.
With the current market price of 187.83 USD, the upside of Inspire Medical Systems Inc is
-97.06%.
INSP Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| DCF (Growth 5y) |
(378.74) - (88.55) |
(142.88) |
-176.1% |
| DCF (Growth 10y) |
(120.88) - (484.86) |
(189.31) |
-200.8% |
| DCF (EBITDA 5y) |
(27.94) - (39.94) |
(1,234.50) |
-123450.0% |
| DCF (EBITDA 10y) |
(39.85) - (48.71) |
(1,234.50) |
-123450.0% |
| Fair Value |
5.51 - 5.51 |
5.51 |
-97.06% |
| P/E |
60.10 - 90.66 |
63.46 |
-66.2% |
| EV/EBITDA |
18.23 - 32.93 |
26.37 |
-86.0% |
| EPV |
(16.45) - (21.94) |
(19.19) |
-110.2% |
| DDM - Stable |
10.61 - 46.42 |
28.51 |
-84.8% |
| DDM - Multi |
(1.39) - (4.77) |
(2.16) |
-101.1% |
INSP Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
5,629.27 |
| Beta |
-0.03 |
| Outstanding shares (mil) |
29.97 |
| Enterprise Value (mil) |
5,481.75 |
| Market risk premium |
4.60% |
| Cost of Equity |
8.71% |
| Cost of Debt |
5.00% |
| WACC |
6.84% |